OncoCyte Corporation (OCX) Financials
OCX Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-09-30 | 81.6 million | 44.0 million |
| 2023-06-30 | 87.5 million | 43.9 million |
| 2023-03-31 | 100.1 million | 65.8 million |
| 2022-12-31 | 100.1 million | 65.8 million |
OCX Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-09-30 | -2.3 million | 608000 |
| 2023-06-30 | -6.8 million | 834000 |
| 2023-03-31 | -10.5 million | 2.6 million |
| 2022-12-31 | -10.5 million | 2.6 million |
OCX Net Income
No data available :(
OCX Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-09-30 | 14.2 million | - | 3.1 million |
| 2023-06-30 | 17.9 million | - | 3.1 million |
| 2023-03-31 | 20.4 million | - | 3.3 million |
| 2022-12-31 | - | - | 3.5 million |
OCX Shares Outstanding
OCX Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-09-30 | 17000 | 2.2 million | 2.5 million | 713000 |
| 2023-06-30 | - | 2.4 million | 3.8 million | 81000 |
| 2023-03-31 | 802000 | 7.8 million | 3.4 million | 589000 |
| 2022-12-31 | 802000 | 7.8 million | 4.0 million | - |
OCX Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-09-30 | 429000 | 181000 |
| 2023-06-30 | 463000 | 191000 |
| 2023-03-31 | 297000 | 287000 |
| 2022-12-31 | 274000 | 301000 |
OCX
Price: $2.49
52 week price:
Earnings Per Share: -3.37 USD
P/E Ratio: -0.89
Exchange: NCM
Sector: Healthcare
Industry: Diagnostics & Research
Volume: 412400
Market Capitalization: 22.4 million